Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-07-07 | Ms. Katz was appointed to the Board of Directors of the Company in October 2016. Ms. Katz is a member of the Audit Committee and the Nominating and Corporate Governance Committee. Director compensation table shows total compensation of $14,279. |
| 2018-07-09 | Nancy E. Katz—59: Ms. Katz was appointed to the Board of Directors of the Company in October 2016. ... Ms. Katz is a member of the Audit Committee and the Nominating and Corporate Governance Committee. |
| 2019-07-10 | Ms. Katz was appointed to the Board of Directors of the Company in October 2016. Ms. Katz is a member of the Audit Committee and the Nominating and Corporate Governance Committee. |
| 2020-07-15 | Ms. Katz was appointed to the Board of Directors of the Company in October 2016. Ms. Katz is a member of the Audit Committee and the Nominating and Corporate Governance Committee. |
| 2021-07-15 | Ms. Katz was appointed to the Board of Directors of the Company in October 2016. Ms. Katz served as Vice President, Consumer Marketing at Medtronic, Inc., a medical technology company, from May 2011 to August 2014. From July 2005 to July 2010, Ms. Katz was Senior Vice President, Bayer Diabetes Care — North America. Prior to this position, she was President and Chief Executive Officer of Calypte Biomedical Corporation, a manufacturer of HIV diagnostics, President of Zila Pharmaceutical, Inc., a manufacturer of oral care products, and held senior marketing positions with the Lifescan division of Johnson & Johnson (blood glucose diabetes products), Schering-Plough Healthcare Products, and with American Home Products. She has previously served on the Boards of Directors of Neoprobe Corporation, Calypte Biomedical Corporation, LXN Corporation and Pepgen Corporation. She currently serves on the Board of NeuroMetrix, Inc. She received a B.S. in business from the University of South Florida. Ms. Katz has significant experience as an executive and director of public companies and provides valuable insight to the Board and management in strategy development and other Company functions. Ms. Katz is a member of the Audit Committee and the Nominating and Corporate Governance Committee. Total compensation: $64,000. |
Data sourced from SEC filings. Last updated: 2025-08-30